Prokarium
PrivateLast Round
Corporate Funding
Dec 2, 2025
Total Funding Raised
$73.47M
Company Overview
Prokarium is a biopharmaceutical company specializing in microbial immunotherapy, aiming to develop innovative living cures for oncology by leveraging synthetic biology to create next-generation immuno-oncology therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prokarium Comps
Public and private peers based on sector, stage, and business model.
Prokarium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 2, 2025 | ||||
| Grant | Mar 14, 2024 | ||||
| Series C | Feb 9, 2023 | ||||
| Series B | Oct 27, 2020 | ||||
| Grant | Oct 8, 2019 | ||||
Series A | Feb 26, 2018 |
Key People
Founding team and executive leadership
Prokarium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flerie Invest | Series B, Series A, Series C |
| Innovate UK | Grant |
| SynbiCITE | Grant, Series C |
| Korea Investment Holdings | Series C |
| Biotechnology and Biological Sciences Research Council | Grant |
| Korea Investment Partners | Series A, Series B |
| Korea Investment Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Will present interim clinical data at the 2026 AUA Annual Meeting.
- Mar 13, 2026
Will present interim clinical data at the EAU Annual Congress in London.
Prokarium Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prokarium's valuation, stock price, and market status.
